Abstract Submission

BE A PART OF THE 2023 WORLD CONGRESS ON BRAIN INJURY!

The International Brain Injury Association welcomes the submission of original research and clinical findings on a broad range of brain injury topics and subspecialties. Submissions will be peer-reviewed and accepted abstracts will be presented oral presentations or posters.

All accepted abstracts will be published in a special edition of IBIA’s official journal, Brain Injury.

Abstract Submission Deadline: Friday, September 30, 2022 at 11:59pm PST.

 

Abstract Guidelines

Abstract Title

  • Should be sentence case (i.e., only the first letter of the title should be capitalized)
  • Should be plain text (No html)
  • Word Limit: 75 words/ 200 characters

Abstract Body

  • Word Limit: 450 words
  • Figures and tables are not allowed
  • Should be in a single paragraph
  • If subheaders are used, they should be within that single paragraph in all-caps, not bolded (e.g., METHODS:)
  • If you use the greater than/equal to symbol, you MUST put a space before entering the number.
  • Abstracts should be data-driven and must include this information in the body of the abstract.
  • Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. IBIA neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors.

Authors

  • There can only be 1 presenting author per submission.
  • There is a maximum of 50 co-authors per abstract submission.
  • Enter the names of authors in the order in which you wish them to appear in the printed text.
  • The name used in the abstract submission will be displayed as the presenter in the online agenda.
  • Emails sent by IBIA to abstract presenters will be sent to the email address provided in the abstract submission.
  • It is the responsibility of that recipient to ensure that the actual presenter receives all communications from the time of submission until after the conference.
  • Presenting authors will be required to register if accepted.

General Guidelines

  • Please make sure your abstract contains only generic drugs names. Abstracts with trade names in the title or body could be precluded from presentation.
  • Please be sure to carefully check your submission for content errors. IBIA neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors. Errors made on your submitted abstract are likely to appear in print.
  • Please be sure to verify the presenters email address. All communication regarding the abstract will be sent to the presenting author’s email address that was entered at the time of submission.

Registration Requirements

If your abstract is accepted for presentation at the IBIA World Congress, the presenting author is required to register for the meeting by the presenter registration deadline. If the presenting author does not register for the IBIA World Congress by this deadline, their abstract will be withdrawn from the program. Additional registration details will be provided in the acceptance email.

Abstract Categories

  • Hypoxic and Ischemic Brain Injury – allied healthcare issues
  • Hypoxic and Ischemic Brain Injury – case reports, case series, observational studies, treatment studies
  • Hypoxic and Ischemic Brain Injury – epidemiology, health services, and outcomes research
  • Hypoxic and Ischemic Brain Injury – laboratory research
  • Hypoxic and Ischemic Brain Injury – neurorehabilitation
  • Hypoxic and Ischemic Brain Injury – neurotechnology
  • Hypoxic and Ischemic Brain Injury – prevention, public health, and public policy
  • Hypoxic and Ischemic Brain Injury – neuro-economics
  • Hypoxic and Ischemic Brain Injury – brain health to neuro-rehabilitation
  • Traumatic Brain Injury – allied healthcare issues
  • Traumatic Brain Injury – case reports, case series, observational studies, treatment studies
  • Traumatic Brain Injury – epidemiology, health services, and outcomes research
  • Traumatic Brain Injury – laboratory research
  • Traumatic Brain Injury – neurorehabilitation
  • Traumatic Brain Injury – neurotechnology
  • Traumatic Brain Injury – prevention, public health, and public policy
  • Traumatic Brain Injury – neuro-economics
  • Traumatic Brain Injury – brain health to neuro-rehabilitation
  • Vascular Brain Injury – allied healthcare issues
  • Vascular Brain Injury – case reports, case series, observational studies, treatment studies
  • Vascular Brain Injury – epidemiology, health services, and outcomes research
  • Vascular Brain Injury – laboratory research
  • Vascular Brain Injury – neurorehabilitation
  • Vascular Brain Injury – neurotechnology
  • Vascular Brain Injury – prevention, public health, and public policy
  • Vascular Brain Injury – neuro-economics
  • Vascular Brain Injury – brain health to neuro-rehabilitation
  • Other Brain Injury – allied healthcare issues
  • Other Brain Injury – case reports, case series, observational studies, treatment studies
  • Other Brain Injury – epidemiology, health services, and outcomes research
  • Other Brain Injury – laboratory research
  • Other Brain Injury – neurorehabilitation
  • Other Brain Injury – neurotechnology
  • Other Brain Injury – prevention, public health, and public policy
  • Other Brain Injury – neuro-economics
  • Other Brain Injury – brain health to neuro-rehabilitation
  • Other Brain Injury – brain injury and covid related issues
Follow by Email
LinkedIn
Share